questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Esterases
Carboxylic ester hydrolases
Phospholipases A
Phospholipases A2
Calcium-independent phospholipase A2
Calcium-independent phospholipase A2 : Questions médicales fréquentes
Diagnostic
5
Phospholipases A2
Diagnostic
Phospholipases A2
Tests sanguins
Biomarqueurs
Phospholipases A2
Symptômes
Phospholipases A2
Imagerie médicale
Phospholipases A2
Symptômes
5
Inflammation
Phospholipases A2
Maladies cardiovasculaires
Phospholipases A2
Carence
Phospholipases A2
Inflammation
Phospholipases A2
Système immunitaire
Phospholipases A2
Prévention
5
Prévention
Phospholipases A2
Habitudes alimentaires
Phospholipases A2
Exercice physique
Phospholipases A2
Suppléments
Phospholipases A2
Traitements
5
Inhibiteurs
Phospholipases A2
Anti-inflammatoires
Phospholipases A2
Thérapies biologiques
Phospholipases A2
Nutrition
Phospholipases A2
Traitements naturels
Phospholipases A2
Complications
5
Complications
Phospholipases A2
Cancers
Phospholipases A2
Inflammation chronique
Phospholipases A2
Risques cardiovasculaires
Phospholipases A2
Système nerveux
Phospholipases A2
Facteurs de risque
5
Facteurs de risque
Phospholipases A2
Diabète
Phospholipases A2
Stress oxydatif
Phospholipases A2
Prédispositions génétiques
Phospholipases A2
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Calcium-independent phospholipase A2 : Questions médicales les plus fréquentes",
"headline": "Calcium-independent phospholipase A2 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Calcium-independent phospholipase A2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Calcium-independent phospholipase A2"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phospholipases A2",
"url": "https://questionsmedicales.fr/mesh/D054467",
"about": {
"@type": "MedicalCondition",
"name": "Phospholipases A2",
"code": {
"@type": "MedicalCode",
"code": "D054467",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.352.100.680.750.937"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Group VI Phospholipases A2",
"alternateName": "Group VI Phospholipases A2",
"url": "https://questionsmedicales.fr/mesh/D054522",
"about": {
"@type": "MedicalCondition",
"name": "Group VI Phospholipases A2",
"code": {
"@type": "MedicalCode",
"code": "D054522",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.352.100.680.750.937.300.249"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Calcium-independent phospholipase A2",
"alternateName": "Phospholipases A2, Calcium-Independent",
"code": {
"@type": "MedicalCode",
"code": "D054512",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Shulin Hou",
"url": "https://questionsmedicales.fr/author/Shulin%20Hou",
"affiliation": {
"@type": "Organization",
"name": "The First Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China; Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. Electronic address: hou_shulin1@163.com."
}
},
{
"@type": "Person",
"name": "Junping Bai",
"url": "https://questionsmedicales.fr/author/Junping%20Bai",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China."
}
},
{
"@type": "Person",
"name": "Jun Xie",
"url": "https://questionsmedicales.fr/author/Jun%20Xie",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. Electronic address: junxie@sxmu.edu.cn."
}
},
{
"@type": "Person",
"name": "Shuntaro Hara",
"url": "https://questionsmedicales.fr/author/Shuntaro%20Hara",
"affiliation": {
"@type": "Organization",
"name": "Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo 142-8555, Japan. Electronic address: haras@pharm.showa-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Emiko Yoda",
"url": "https://questionsmedicales.fr/author/Emiko%20Yoda",
"affiliation": {
"@type": "Organization",
"name": "Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo 142-8555, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular basis of unique specificity and regulation of group VIA calcium-independent phospholipase A",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/36990122",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pharmthera.2023.108395"
}
},
{
"@type": "ScholarlyArticle",
"name": "Myeloid-specific deletion of group VIA calcium-independent phospholipase A2 induces pro-inflammatory LPS response predominantly in male mice via MIP-1α activation.",
"datePublished": "2024-01-09",
"url": "https://questionsmedicales.fr/article/38198970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbadis.2024.167016"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Serum Albumin and Secretory Phospholipase A2 in Sepsis.",
"datePublished": "2024-08-30",
"url": "https://questionsmedicales.fr/article/39273360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179413"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.",
"datePublished": "2022-06-17",
"url": "https://questionsmedicales.fr/article/35784308",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.905930"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sucrose Treatment Enhances the Electrotransfer of DNA by Activating Phospholipase A2.",
"datePublished": "2024-03-29",
"url": "https://questionsmedicales.fr/article/38675136",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics16040475"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Esterases",
"item": "https://questionsmedicales.fr/mesh/D004950"
},
{
"@type": "ListItem",
"position": 6,
"name": "Carboxylic ester hydrolases",
"item": "https://questionsmedicales.fr/mesh/D002265"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phospholipases A",
"item": "https://questionsmedicales.fr/mesh/D010741"
},
{
"@type": "ListItem",
"position": 8,
"name": "Phospholipases A2",
"item": "https://questionsmedicales.fr/mesh/D054467"
},
{
"@type": "ListItem",
"position": 9,
"name": "Calcium-independent phospholipase A2",
"item": "https://questionsmedicales.fr/mesh/D054512"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Calcium-independent phospholipase A2 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Calcium-independent phospholipase A2",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Calcium-independent phospholipase A2",
"description": "Comment diagnostiquer une activité de phospholipase A2 ?\nQuels tests sanguins sont utiles pour évaluer cette enzyme ?\nY a-t-il des biomarqueurs associés à cette enzyme ?\nQuels symptômes peuvent indiquer une dysfonction de cette enzyme ?\nComment les imageries médicales aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D054512#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Calcium-independent phospholipase A2",
"description": "Quels sont les symptômes d'une suractivité de la phospholipase A2 ?\nLa phospholipase A2 est-elle liée à des maladies spécifiques ?\nQuels signes cliniques sont associés à une carence ?\nComment l'inflammation est-elle liée à cette enzyme ?\nPeut-elle affecter le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D054512#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Calcium-independent phospholipase A2",
"description": "Comment prévenir les dysfonctionnements de la phospholipase A2 ?\nY a-t-il des habitudes à éviter ?\nL'exercice physique influence-t-il cette enzyme ?\nLe stress a-t-il un impact sur cette enzyme ?\nDes suppléments peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D054512#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Calcium-independent phospholipase A2",
"description": "Quels traitements ciblent la phospholipase A2 ?\nLes anti-inflammatoires aident-ils contre cette enzyme ?\nY a-t-il des thérapies biologiques disponibles ?\nComment la nutrition influence-t-elle cette enzyme ?\nLes traitements naturels sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D054512#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Calcium-independent phospholipase A2",
"description": "Quelles complications peuvent survenir avec une suractivité ?\nLa phospholipase A2 est-elle liée à des cancers ?\nComment l'inflammation chronique affecte-t-elle la santé ?\nY a-t-il des risques cardiovasculaires associés ?\nQuels effets sur le système nerveux ?",
"url": "https://questionsmedicales.fr/mesh/D054512#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Calcium-independent phospholipase A2",
"description": "Quels facteurs augmentent le risque d'activité élevée ?\nL'âge influence-t-il l'activité de cette enzyme ?\nLe diabète est-il un facteur de risque ?\nLe stress oxydatif joue-t-il un rôle ?\nY a-t-il des prédispositions génétiques ?",
"url": "https://questionsmedicales.fr/mesh/D054512#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activité de phospholipase A2 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques mesurant l'activité de la phospholipase A2 dans des échantillons biologiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour évaluer cette enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages d'enzymes et les marqueurs inflammatoires peuvent indiquer l'activité de la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biomarqueurs comme les acides gras libres peuvent être mesurés pour évaluer l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une dysfonction de cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes inflammatoires ou des troubles métaboliques peuvent suggérer une dysfonction."
}
},
{
"@type": "Question",
"name": "Comment les imageries médicales aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les imageries peuvent révéler des inflammations ou des lésions tissulaires associées à l'activité de l'enzyme."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une suractivité de la phospholipase A2 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Inflammation, douleur, et troubles métaboliques peuvent survenir en cas de suractivité."
}
},
{
"@type": "Question",
"name": "La phospholipase A2 est-elle liée à des maladies spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est impliquée dans des maladies comme l'arthrite et certaines maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une carence ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence peut entraîner des troubles de la membrane cellulaire et des problèmes de signalisation."
}
},
{
"@type": "Question",
"name": "Comment l'inflammation est-elle liée à cette enzyme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La phospholipase A2 libère des acides gras pro-inflammatoires, exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Peut-elle affecter le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle dans la modulation de la réponse immunitaire et l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements de la phospholipase A2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une alimentation équilibrée et un mode de vie sain peut aider à prévenir les dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments riches en acides gras trans peut réduire l'activité de la phospholipase A2."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il cette enzyme ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler l'activité de la phospholipase A2 et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur cette enzyme ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut augmenter l'activité de la phospholipase A2, exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments d'oméga-3 peuvent aider à réguler l'activité de la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent la phospholipase A2 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques de la phospholipase A2 sont utilisés pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires aident-ils contre cette enzyme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires non stéroïdiens peuvent réduire l'activité de la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies biologiques disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies biologiques ciblent les voies inflammatoires impliquant la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Comment la nutrition influence-t-elle cette enzyme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en acides gras oméga-3 peut moduler l'activité de la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Les traitements naturels sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains extraits de plantes peuvent avoir des effets inhibiteurs sur la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une suractivité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut entraîner des maladies inflammatoires chroniques et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "La phospholipase A2 est-elle liée à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, son activité est associée à certains types de cancers, notamment le cancer du sein."
}
},
{
"@type": "Question",
"name": "Comment l'inflammation chronique affecte-t-elle la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation chronique peut mener à des complications cardiovasculaires et métaboliques graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques cardiovasculaires associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activité élevée de la phospholipase A2 est liée à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels effets sur le système nerveux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut contribuer à des troubles neurodégénératifs en raison de l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'activité élevée ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et une alimentation riche en graisses saturées augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il l'activité de cette enzyme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé est associé à une augmentation de l'activité de la phospholipase A2."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter l'activité de la phospholipase A2, exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut stimuler l'activité de la phospholipase A2, augmentant l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines variations génétiques peuvent prédisposer à une activité accrue de la phospholipase A2."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
The First Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China; Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. Electronic address: hou_shulin1@163.com.
Publications dans "Calcium-independent phospholipase A2" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Publications dans "Calcium-independent phospholipase A2" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China. Electronic address: junxie@sxmu.edu.cn.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo 142-8555, Japan. Electronic address: haras@pharm.showa-u.ac.jp.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo 142-8555, Japan.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo 142-8555, Japan.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo 142-8555, Japan.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
Department of Biochemistry, Faculty of Pharmacy, University of Sadat City, Monufia, Egypt.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada. andrey.cybulsky@mcgill.ca.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Key Laboratory for Cellular Physiology of Ministry of Education, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China; Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA. Electronic address: jshayman@umich.edu.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Purdue University, West Lafayette, IN, USA.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Internal Medicine IV, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161, Thailand.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), German Centre for Cardiovascular Research, Partner Site, University of Heidelberg, Germany.
Publications dans "Calcium-independent phospholipase A2" :
2 publications dans cette catégorie
Affiliations :
Internal Medicine IV, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Publications dans "Calcium-independent phospholipase A2" :
Glycerophospholipids are major components of cell membranes and consist of a glycerol backbone esterified with one of over 30 unique fatty acids at each of the sn-1 and sn-2 positions. In addition, in...
Polymorphisms of group VIA calcium-independent phospholipase A2 (PLA2G6) are associated with blood C-reactive protein suggesting its role in inflammation. We showed that myeloid-specific Pla2g6-defici...
Sepsis is caused by a dysregulated host response to an infection that leads to cascading cell death and eventually organ failure. In this study, the role of inflammatory response serum secretory phosp...
The anti-phospholipase A2 receptor (PLA2R) antibody is a non-invasive diagnostic tool and prognosis predictor of idiopathic membranous nephropathy (IMN). Baseline hypercholesterolemia independently pr...
A total of 495 IMN patients identified by kidney biopsy in Wuhan Tongji Hospital, China, from January 2016 through December 2020 were enrolled in this study. Data on clinical features, pathology findi...
Total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) were positively related to proteinuria, indicating dama...
Hypercholesterolemia is a potentially useful biomarker for disease severity, serum anti-PLA2R antibody, glomerular PLA2R deposit, and proteinuria outcome of IMN....
Our previous study discovered that sucrose and other non-reducing sugars (e.g., trehalose and raffinose) could be used to improve the electrotransfer (ET) of molecular cargo, including DNA, mRNA, and ...
Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been recognized as a valuable biomarker for identifying the risk of cardiovascular diseases and inflammation. Furthermore, there is strong evidenc...
To explore the relationship between Lp-PLA2 levels and metabolic syndrome, and to establish the predictive cut-off value of Lp-PLA2, a retrospective analysis was conducted using medical data from a sa...
The analysis of the data indicated that participants had a mean age of 44.2 years, a mean Lp-PLA2 level of 589 IU/L, and a metabolic syndrome prevalence of 22%. Lp-PLA2 levels were significantly diffe...
Our findings suggest that Lp-PLA2 may serve as a useful biomarker for identifying individuals at risk of developing metabolic syndrome, particularly in females. Further research is needed to explore t...
Secreted phospholipase A2s (sPLA2s) are a group of enzymes with 6-8 disulfide bonds that participate in numerous physiological processes by catalyzing the hydrolysis of phospholipids at the sn-2 posit...
Although benign hepatocellular adenomas (HCA) are very rare, recent observations have shown their occurrence in patients with diabetes mellitus. Consequently, most of these cases are treated by resect...
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory factor in the pathogenesis of atherosclerotic plaque and is associated with an increased risk of ischemic stroke. Whether Lp-PLA2 i...
A total of 126 eligible AIS patients were divided into four groups: (1) no cerebral artery stenosis (NCS); (2) intracranial artery stenosis (ICAS); (3) extracranial artery stenosis (ECAS); and (4) com...
The ICAS group had a lower frequency of dyslipidemia as compared to the NCS group and the IECS group (35.3% vs. 70% vs. 71.8%, respectively,...
Elevated Lp-PLA2 levels were differentially associated with increased risk in AIS patients with ICAS compared to those with ECAS or no stenosis. Lp-PLA2 may be a promising biomarker and potential ther...
The food enzyme phospholipase A2 (phosphatidylcholine 2-acylhydrolase EC 3.1.1.4) is produced with the genetically modified...